Emerging role of circular RNAs in breast cancer

Soudeh Ghafouri-Fard1, Bashdar Mahmud Hussen2, Mohammad Taheri3

  • 1Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Insights

Circular RNAs (circRNAs) play key roles in breast cancer development. These non-coding RNAs influence tumor growth and treatment resistance, often by acting as miRNA sponges.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Circular RNAs (circRNAs) are non-coding RNA molecules with diverse regulatory functions.
  • circRNAs can influence gene expression by acting as miRNA sponges, interacting with RNA-binding proteins, and affecting transcription and splicing.
  • Emerging evidence highlights the significant involvement of circRNAs in the progression of breast cancer.

Purpose of the Study:

  • To review and synthesize current research on the role of circRNAs in breast cancer.
  • To elucidate the mechanisms by which circRNAs contribute to breast cancer development and progression.

Main Methods:

  • Literature review of studies investigating circRNAs in breast cancer.
  • Analysis of microarray data identifying differentially expressed circRNAs in breast cancer samples.
  • Examination of mechanistic studies detailing circRNA functions in cancer.

Main Results:

  • circRNAs exhibit altered expression patterns in breast cancer, with some upregulated (e.g., circ-TFF1, circPLK1) and others downregulated (e.g., hsa_circ_0000375, circYap).
  • These circRNAs impact critical cancer hallmarks, including tumor growth, metastasis, stemness, and therapeutic resistance.
  • A primary mechanism involves circRNAs sequestering microRNAs (miRNAs), thereby modulating miRNA target gene expression.

Conclusions:

  • circRNAs are integral regulators in breast cancer pathogenesis.
  • Dysregulation of specific circRNAs contributes to various aspects of breast cancer.
  • Targeting circRNAs or their interactions may offer novel therapeutic strategies for breast cancer.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.7K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
9.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K